Nicola King

Dr. Nicola King

Lecturer in Cardiac Physiology, School of Biomedical Sciences, University of Plymouth, Plymouth PL4 8AA, UK

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2016 in International Journal of Cardiology
Verified
Journal Article
Closed access
GDGudrun Dieberg
Gudrun Dieberg
NSNeil A. Smart
Neil A. Smart
Nicola KingNicola King
Nicola King

1 March 2018 in JACC
Verified
Journal Article
Closed access
NSNeil A. Smart
Neil A. Smart
GDGudrun Dieberg
Gudrun Dieberg
Nicola KingNicola King
Nicola King

1 November 2016 in International Journal of Cardiology
Verified
Journal Article
Closed access
GDGudrun Dieberg
Gudrun Dieberg
NSNeil A. Smart
Neil A. Smart
Nicola KingNicola King
Nicola King

1 August 2018 in Medicine
Verified
Journal Article
Open access
ARAlexander C. Reynolds
Alexander C. Reynolds
Nicola KingNicola King
Nicola King
Hybrid coronary revascularization (HCR) combining minimally invasive grafting of the left internal mammary artery to the left anterior descending artery with percutaneous coronary intervention has become a viable option for treating coronary artery disease. The aim of this meta-analysis was to compare HCR with conventional coronary artery bypass grafting (CABG) in a range of clinical outcomes and hospital costs. To identify potential studies, systematic searches were carried out in various databases. The key search terms included “hybrid revascularization” AND “coronary artery bypass grafting” OR “HCR” OR “CABG.” This was followed by a meta-analysis investigating the need for blood transfusion, hospital costs, ventilation time, hospital stay, cerebrovascular accident, myocardial infarction, mortality, postoperative atrial fibrillation, renal failure, operation duration, and ICU stay. The requirement for blood transfusion was significantly lower for HCR: odds ratio 0.38 (95% confidence intervals [CIs] 0.31–0.46, P < .00001) as was the hospital stay: mean difference (MD) −1.48 days (95% CI, −2.61 to −0.36, P = 0.01) and the ventilation time: MD −8.99 hours (95% CI, −15.85 to −2.13, P = .01). On the contrary, hospital costs were more expensive for HCR: MD $3970 (95% CI, 2570–5370, P < .00001). All other comparisons were insignificant. In the short-term, HCR is as safe as conventional CABG and may offer certain benefits such as a lower requirement for blood transfusion and shorter hospital stays. However, HCR is more expensive than conventional CABG.

1 May 2018 in Biochimica et Biophysica Acta (BBA) - Biomembranes
Verified
Journal Article
Closed access
OAOthman A. Alghamdi
Othman A. Alghamdi
Nicola KingNicola King
Nicola King
GJGraham Jones
Graham Jones
PMPierre D.J. Moens
Pierre D.J. Moens

17 July 2018 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
OAOthman A. Alghamdi
Othman A. Alghamdi
Nicola KingNicola King
Nicola King
NANicholas M. Andronicos
Nicholas M. Andronicos
GJGraham L. Jones
Graham L. Jones
BCBelal Chami
Belal Chami
PMPierre D. J. Moens
Pierre D. J. Moens